Research & KnowledgeEvent: September 2, 2026
PercuSense conducted a recently started ICU study where a PercuSense continuous metabolic sensor was placed into a patient six hours after an out-of-hospital cardiac arrest.
Published
Signal category
Research & Knowledge
Quote
“As part of our recently started ICU study, a PercuSense continuous metabolic sensor was placed into a patient who arrived in the ICU study six hours after an out-of-hospital cardiac arrest.”
— PercuSense team
Company
PercuSense
Intelligent biosensors to power the future of healthcare
- Industry
- Medical Device
- Location
- Valencia, US
- Company size
- 13 employees
PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment.